Compound | Virgin | Parous | ||
---|---|---|---|---|
Control | Supplementary | Control | Supplementary | |
DA (ng/g) | 5.3 ± 0.6 | 5.4 ± 1.2 | 2.2 ± 0.3## | 3.4 ± 0.3# |
DOPAC (ng/g) | 6.8 ± 0.9 | 10.1 ± 1.9 | 10.1 ± 1.0 | 7.7 ± 0.5 |
HVA (ng/g) | 1.1 ± 0.2 | 1.3 ± 0.3 | 1.3 ± 0.1 | 1.8 ± 0.2 |
NE (ng/g) | 8.2 ± 1.8 | 3.8 ± 0.9** | 3.3 ± 0.6## | 5.9 ± 0.7 |
MHPG (ng/g) | 0.7 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 1.1 ± 0.1 |
VMA(ng/g) | 1.2 ± 0.1 | 2.0 ± 0.4* | 0.6 ± 0.1 | 0.5 ± 0.1## |
TRY (ug/g) | 9.2 ± 1.6 | 6.7 ± 1.4 | 8.2 ± 0.7 | 12.0 ± 1.0##,* |
5-HT (ng/g) | 153.7 ± 14.0 | 127.7 ± 31.3 | 116.0 ± 14.6 | 178.6 ± 26.1 |
5-HIAA (ng/g) | 373.9 ± 45.6 | 355.6 ± 27.0 | 304.0 ± 25.8 | 215.3 ± 11.02##,* |
5-HIAA/5-HT | 3.0 ± 0.4 | 3.2 ± 0.8 | 2.8 ± 0.4 | 1.2 ± 0.2#,* |
KYN (ng/g) | 540.7 ± 99.0 | 429.0 ± 101.2 | 526.1 ± 51.4 | 622.2 ± 58.8 |
GABA (ug/g) | 292.6 ± 41.5 | 200.3 ± 49.8 | 602.7 ± 82.8## | 730.1 ± 99.2## |
GLU (ug/g) | 0.4 ± 0.06 | 0.3 ± 0.05 | 0.5 ± 0.06 | 0.7 ± 0.07 |
GLN (ug/g) | 178.2 ± 25.2 | 132.0 ± 35.8 | 356.7 ± 41.5# | 501.0 ± 64.2## |